The Company announced a 10-year agreement with FUJIFILM Diosynth Biotechnologies (Fujifilm) to manufacture and supply Regeneron's commercial bulk drug product at Fujifilm's North Carolina campus. The ...

Regeneron has signed a collaboration deal ... with the lead party retaining global development and commercial responsibility. For CNS programs, both companies will have the option at candidate ...

We think the firm does face environmental, social, and governance risks, particularly related to US drug price-related policy changes (roughly 80% of Regeneron's revenue for top-selling drugs ...